COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 177 filers reported holding COHERUS BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $656,374 | -55.8% | 175,501 | -19.1% | 0.00% | -75.0% |
| Q1 2023 | $1,484,588 | -36.6% | 217,045 | -26.6% | 0.00% | -33.3% |
| Q4 2022 | $2,343,346 | -69.5% | 295,877 | -63.0% | 0.01% | -75.0% |
| Q3 2022 | $7,687,000 | -28.7% | 799,950 | -46.2% | 0.02% | -31.4% |
| Q2 2022 | $10,774,000 | +351.2% | 1,488,109 | +1162.6% | 0.04% | +118.8% |
| Q3 2019 | $2,388,000 | -71.2% | 117,864 | -68.8% | 0.02% | -69.8% |
| Q2 2019 | $8,287,000 | +72.4% | 377,199 | +7.0% | 0.05% | +65.6% |
| Q1 2019 | $4,806,000 | +483.3% | 352,370 | +286.8% | 0.03% | +433.3% |
| Q4 2018 | $824,000 | -10.5% | 91,101 | +63.2% | 0.01% | +50.0% |
| Q3 2018 | $921,000 | -79.5% | 55,831 | -82.6% | 0.00% | -80.0% |
| Q2 2018 | $4,485,000 | +2651.5% | 320,323 | +2071.5% | 0.02% | +1900.0% |
| Q1 2018 | $163,000 | – | 14,751 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 650,000 | $10,374,000 | 2.09% |
| CM Management, LLC | 125,000 | $1,995,000 | 1.51% |
| Perceptive Advisors | 10,815,596 | $172,616,000 | 1.33% |
| Bridge City Capital, LLC | 163,198 | $2,605,000 | 1.07% |
| Phocas Financial Corp. | 514,438 | $8,210,000 | 1.04% |
| Redwood Investments, LLC | 709,184 | $11,319,000 | 0.89% |
| Aristotle Capital Boston, LLC | 2,087,187 | $33,312,000 | 0.78% |
| Knott David M Jr | 102,555 | $1,637,000 | 0.56% |
| Zebra Capital Management LLC | 16,746 | $267,000 | 0.43% |
| Temasek Holdings (Private) Ltd | 7,381,116 | $117,803,000 | 0.42% |